Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Non-invasive Test to Detect Intra-amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and and Intact Amniotic Membranes

NCT00700219 is registered in ClinicalTrials.gov with ProteoGenix, Inc. as lead sponsor.

NCT NCT00700219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00700219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Non-invasive Test to Detect Intra-amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and and Intact Amniotic Membranes
Lead sponsor
ProteoGenix, Inc.
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2008
Completion date
September 30, 2010
Enrollment
900 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

intra-amniotic infection